MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism

被引:55
|
作者
Ji, Weidong [1 ]
Yang, Lei [2 ]
Yuan, Jianhui [3 ]
Yang, Linqing [3 ]
Zhang, Mei [4 ]
Qi, Defeng [1 ]
Duan, Xiaolu [1 ]
Xuan, Aiguo [5 ]
Zhang, Wenjuan [6 ]
Lu, Jiachun [2 ]
Zhuang, Zhixiong [3 ]
Zeng, Guohua [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol,Minimally Invas Surg Ctr, Guangzhou 510230, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Inst Chem Carcinogenesis, Guangzhou 510182, Guangdong, Peoples R China
[3] Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Peoples R China
[4] Guangzhou Med Univ, Dept Pharmacol, Guangzhou 510182, Guangdong, Peoples R China
[5] Guangzhou Med Univ, Dept Anat, Guangzhou 510182, Guangdong, Peoples R China
[6] Southern Med Univ, Dept Toxicol, Sch Publ Hlth & Trop Med, Guangzhou 510515, Guangdong, Peoples R China
关键词
HISTONE DEMETHYLASE JMJD1A; NICKEL COMPOUNDS; MIRNA GENES; EARLY EVENT; CANCER; METHYLATION; CARCINOGENESIS; HYPERMETHYLATION; EPIGENETICS; INVOLVEMENT;
D O I
10.1093/carcin/bgs343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nickel (Ni) compounds are well-recognized human carcinogens, yet the molecular mechanisms by which they cause human cancer are still not well understood. MicroRNAs (miRNAs), which are small non-coding RNAs, are involved in diverse biological functions and carcinogenesis. In previous study, we identified upregulation of DNA methyltransferase 1 (DNMT1) expression in nickel sulfide (NiS)-transformed human bronchial epithelial (16HBE) cells. Here, we investigated whether some miRNAs are aberrantly expressed and targets DNMT1 in NiS-transformed cells. Our results showed that the expression of miRNA-152 (miR-152) was specifically downregulated in NiS-transformed cells via promoter DNA hypermethylation, whereas ectopic expression of miR-152 in NiS-transformed cells resulted in a marked reduction of DNMT1 expression. Further experiments revealed that miR-152 directly downregulated DNMT1 expression by targeting the 3' untranslated regions of its transcript. Interestingly, treatment of DNMT inhibitor, 5-aza-2-deoxycytidine, or depletion of DNMT1 led to increased miR-152 expression by reversion of promoter hypermethylation, DNMT1 and MeCP2 binding to miR-152 promoter in NiS-transformed cells. Moreover, inhibition of miR-152 expression in 16HBE cells could increase DNMT1 expression and result in an increase in DNA methylation, DNMT1 and MeCP2 binding to miR-152 promoter, indicating an interaction between miR-152 and DNMT1 is regulated by a double-negative circuit. Furthermore, ectopic expression of miR-152 in NiS-transformed cells led to a significant decrease of cell growth. Conversely, inhibition of miR-152 expression in 16HBE cells significantly increased cell growth. Taken together, these observations demonstrate a crucial functional crosstalk between miR-152 and the DNMT1 via a feedback loop involved in NiS-induced malignant transformation.
引用
收藏
页码:446 / 453
页数:8
相关论文
共 50 条
  • [41] Epigenetic Regulation of MicroRNA-126 in Scleroderma Is Associated with Upregulation of DNA Methyltransferase-1, Repression of Endothelial Nitric Oxide Synthase Expression, and Enhanced Platelet Adhesion to Endothelial Cells
    Wang, Yongqing
    Kahaleh, Bashar
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2312 - 2313
  • [42] DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells
    Jing, Wei
    Song, Na
    Liu, Yunpeng
    Qu, Xiujuan
    Hou, Kezuo
    Yang, Xianghong
    Che, Xiaofang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 117 - 124
  • [43] Calcitonin gene-related peptide inhibits human immunodeficiency type 1 transmission by Langerhans cells via an autocrine/paracrine feedback mechanism
    Ganor, Y.
    Drillet-Dangeard, A. -S.
    Bomsel, M.
    ACTA PHYSIOLOGICA, 2015, 213 (02) : 432 - 441
  • [44] 5-Aza-2′-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status
    Liu, Juan
    Zhang, Yan
    Xie, Yi-Shan
    Wang, Fu-Liang
    Zhang, Li-Jun
    Deng, Tao
    Luo, He-Sheng
    ONCOLOGY REPORTS, 2012, 28 (02) : 545 - 552
  • [45] TET1 Modulates DNA Replication in Leukemia Cells Via a Catalytic-Independent Mechanism through Cooperating with KAT8
    Weng, Hengyou
    Huang, Huilin
    Huang, He
    Yu, Zhaojin
    Siejka-Zielinska, Paulina
    Chen, Zhenhua
    Prince, Emily
    Shen, Chao
    Li, Zejuan
    Song, Chunxiao
    Zhao, Yingming
    Chen, Jianjun
    BLOOD, 2019, 134
  • [46] Baicalein Inhibits Amadori-Glycated Albumin-Induced MCP-1 Expression in Retinal Ganglion Cells via a MicroRNA-124-Dependent Mechanism
    Dong, Ning
    Xu, Bing
    Shi, Hong
    Tang, Xin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (10) : 5844 - 5853
  • [47] Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1
    Zhang, Cheng
    Zou, Ying
    Dai, Dong-Qiu
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 119
  • [48] Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells
    J S You
    J K Kang
    E K Lee
    J C Lee
    S H Lee
    Y J Jeon
    D H Koh
    S H Ahn
    D-W Seo
    H Y Lee
    E-J Cho
    J-W Han
    Oncogene, 2008, 27 : 1376 - 1386
  • [49] Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells
    Nishioka, Chie
    Ikezoe, Takayuki
    Yang, Jing
    Udaka, Keiko
    Yokoyama, Akihito
    LEUKEMIA RESEARCH, 2011, 35 (07) : 932 - 939
  • [50] Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells
    You, J. S.
    Kang, J. K.
    Lee, E. K.
    Lee, J. C.
    Lee, S. H.
    Jeon, Y. J.
    Koh, D. H.
    Ahn, S. H.
    Seo, D-W
    Lee, H. Y.
    Cho, E-J
    Han, J-W
    ONCOGENE, 2008, 27 (10) : 1376 - 1386